Drugs / Compound 451238
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03602833 | Nov 2018 → Jun 2023 | soft tissue sarcoma | Royal Marsden NHS Foundation Trust | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound 451238 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03602833 ↗ |
| Route | Intravenous | “administered intravenously once every two weeks” NCT03602833 ↗ |